YR001 / Hangzhou Yirui Pharma - LARVOL DELTA

Topical YR001 Ointment in Adult with Mild to Moderate Atopic Dermatitis (clinicaltrials.gov) - P2 | N=36 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Trial completion date: Jun 2025 ➔ Dec 2025 | Trial primary completion date: Jan 2025 ➔ Dec 2025

Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis (clinicaltrials.gov) - P2 | N=36 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis (clinicaltrials.gov) - P2 | N=36 | Not yet recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers (clinicaltrials.gov) - P1 | N=54 | Completed | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Recruiting ➔ Completed

Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers (clinicaltrials.gov) - P1 | N=54 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers (clinicaltrials.gov) - P1 | N=54 | Not yet recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd

New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis